Description

4-[1-Dimethylamino-3-[2-[2-(4-Dimethylaminophenyl)Ethyl]Phenoxy]Propan-2-Yl]Oxy-4-Oxo-Butanoic Acid Dihydrochloride is a high-purity, complex organic salt primarily utilized as a critical intermediate in advanced pharmaceutical synthesis. Its molecular structure makes it a valuable building block for research and development in medicinal chemistry. This compound is essential for manufacturers and R&D laboratories focused on creating novel active pharmaceutical ingredients (APIs), particularly in specialized therapeutic areas.

Application

• Pharmaceutical Intermediate: Serves as a key synthetic precursor in the development of novel drug candidates and active pharmaceutical ingredients (APIs).
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and the synthesis of complex molecules for biological screening.
• Process Development: Employed in scaling up synthetic routes from laboratory to pilot plant and commercial manufacturing scales.
• Reference Standard: Can be supplied as a high-purity standard for analytical method development, validation, and quality control testing.
• Custom Synthesis: Acts as a starting material for the contract manufacturing of specialized fine chemicals and bespoke molecular entities.

Basic Information

Product Name	4-[1-Dimethylamino-3-[2-[2-(4-Dimethylaminophenyl)Ethyl]Phenoxy]Propan-2-Yl]Oxy-4-Oxo-Butanoic Acid Dihydrochloride
CAS No.	86819-19-4
Molecular Formula	C27H37N2O6 · 2HCl
Molecular Weight	Approx. 553.5 g/mol (Free base) / 626.5 g/mol (Dihydrochloride salt)
Synonyms	4-[1-Dimethylamino-3-[2-[2-(4-Dimethylaminophenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic acid dihydrochloride; Butanoic acid, 4-[1-(dimethylamino)-3-[2-[2-(4-(dimethylamino)phenyl)ethyl]phenoxy]-2-propan-2-yl]oxy]-4-oxo-, dihydrochloride; 86819-19-4; CAS 86819-19-4
EINECS	Contact for details

Quality Control

Our 4-[1-Dimethylamino-3-[2-[2-(4-Dimethylaminophenyl)Ethyl]Phenoxy]Propan-2-Yl]Oxy-4-Oxo-Butanoic Acid Dihydrochloride is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity and spectroscopic identification (NMR, IR, MS), to ensure it meets exacting specifications for pharmaceutical intermediate use. A detailed Certificate of Analysis (COA) is provided with every shipment, confirming identity, purity, and conformity.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive); the container must be kept tightly sealed to exclude moisture and prevent degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.